中国药房2018，Vol.29Issue(6)：721-725,5.DOI:10.6039/j.issn.1001-0408.2018.06.01
我国医疗卫生机构药品不良反应上报指标研究
Research on the Indicators of ADR Reporting by Medical Institutions in China
摘要
Abstract
OBJECTIVE:To evaluate the indicators of ADR reporting by medical institutions in China. METHODS:The indicators of ADR reporting by medical institutions in China were presented primarily by 8 pharmacy experts with focus group interview method. System assessment method was used for evidence-based analysis of primary ADR indicators. Delphi method was used to confirm the requirement,calculation formula,definition,evaluation meaning and reference value of ADR indicators. The reliability was assessed. RESULTS:Primary indicators included the rate of ADR reporting,the rate of qualified ADR,constituent ratio of severe and new ADR. A total of 30 literatures were included(15 documents of management standard,15 literature research)in system evaluation,all of which indicated the necessity and requirement of ADR reporting. But the calculation formula, definition and evaluation meaning of ADR indicators were not mentioned. By investigation with Delphi method,the range of reference value was confirmed as follows that the rate of ADR reporting was≥0.01%;the rate of qualified ADR was≥90%;the constituent ratio of severe and new ADR was≥1%. The evaluation result was reliable. CONCLUSIONS:The indicators of ADR reporting and reference lower limit value can urge medical and health institutions to report ADR actively,improve the quality of ADR reporting and strengthen the attention of medical and health institutions to severe and new ADR.关键词
药品不良反应/上报指标/焦点组访谈法/系统评价法/德尔菲法Key words
ADR/Reporting indicator/Focus group interview/System evaluation/Delphi method分类
医药卫生引用本文复制引用
黄蕊,杨春松,熊堉,林芸竹..我国医疗卫生机构药品不良反应上报指标研究[J].中国药房,2018,29(6):721-725,5.基金项目
国家自然科学基金资助项目(No.71704123) （No.71704123）
2015年城市医院分会四类立项课题 （）
